PharmaBoardroom

Nicolaus Kröger – President, European Society for Blood…

Building on points developed in his 2020 PharmaBoardroom interview, Professor Nicolaus Kröger of the European Society for Blood and Marrow…

Agility, Responsiveness, & Resilience: Five Takeaways from…

Walt Vernon is CEO of US-based healthcare facilities consulting firm, Mazzetti, and non-profit, Sextant. He is on the Board of the FGI and served on…

Pharma Manufacturing in Africa: An Opportunity to Strengthen…

Medicines for Africa's Lenias Hwenda highlights the vast gaps in COVID-19 vaccine access globally, especially in Africa where just six percent of the…

Tisha Boatman – Managing Director, Siemens Healthineers…

In a wide-ranging and candid conversation, Siemens Healthineers' Tisha Boatman discusses uprooting from the US to Denmark, how Danish hospital…

Kenneth Mikkelsen – General Manager Denmark & Jeroen…

Kenneth Mikkelsen & Jeroen ter Borg describe the work of IQVIA - the world's biggest CRO and life science data services provider - in Denmark,…

Estève Speranza – Managing Director Nordic Countries,…

Servier's Estève Speranza outlines the rationale behind the French group's reorganisation in the Nordic countries, how the global shift towards…

Soriot Declares Pandemic Over: AstraZeneca to Start Charging for…

After a tumultuous year, AstraZeneca is creating a standalone vaccine unit and will begin to charge for its COVID-19 vaccine shot, having previously…

Biden’s New FDA Pick Not Without Controversy

Almost ten months into his presidency, Joe Biden has announced his pick to lead the US Food and Drug Administration (FDA). If confirmed by the Senate,…

100 Years of Insulin: An Access to Medicines Issue Writ Large

On the 100th anniversary of the development of insulin, regular PharmaBoardroom contributor Brendan Shaw* examines the shocking global disparities in…

Ashraf Mallak – Managing Director GCC, MSD

After almost two decades with MSD, Ashraf Mallak, managing director for the company in the GCC region, dives into the often-overlooked healthcare…

Carsten Hellmann – President & CEO, ALK

Speaking after the recent completion of a three-year strategic transformation plan, ALK President and CEO Carsten Hellmann outlines the progress made…

Turkey: Biosimilars on the Rise

With an already well-established manufacturing industry for pharmaceuticals, Turkey has been aiming to move with global trends and invest in biologics…

Tagged with R